EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Transformation to Small‐Cell Lung Carcinoma and Then to Sarcomatoid Carcinoma in an EGFR ‐Mutant Lung Adenocarcinoma Patient During Systemic Therapy: A Case Report

Bingyu Huang iD, Tao Lu, Ruping Hong, Xiaoyan Liu iD, Xiaoxing Gao iD, Yan Xu iD, Minjiang Chen iD, Wei Zhong, Mengzhao Wang iD, Jing Zhao

Thoracic Cancer · 2026-11 · 17 (21)

DOI: 10.1111/1759-7714.70397 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Thoracic Cancer, online erschienen am 03.11.2026. Verfasst von Bingyu Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, …. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cell Transformation, Neoplastic, Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peking Union Medical College Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This case exemplifies stepwise histological transformations of an initially EGFR‐mutant lung adenocarcinoma driven by tumor lineage plasticity under therapeutic pressure. Initial resistance to osimertinib manifested as transformation to combined small‐cell lung carcinoma, associated with concurrent TP53/RB1 co‐inactivation and the acquisition of an epidermal growth factor receptor (EGFR) C797S mutation. Subsequent progression after chemotherapy featured a rare sarcomatoid transformation, with the tumor retaining the original EGFR Exon 19 deletion, supporting clonal evolution. This phenotypic shift, indicative of epithelial‐to‐mesenchymal transition (EMT), may have been associated with PTEN loss and potential activation of the PI3K/AKT/mTOR pathway. The serial emergence of neuroendocrine and sarcomatoid phenotypes underscores the critical need for rebiopsy to guide therapy and highlights the profound adaptability of EGFR‐mutant tumors, which remain a major therapeutic challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungCell Transformation, NeoplasticLung NeoplasmsSmall Cell Lung CarcinomaHumansMaleErbB ReceptorsMutationAdult

Stichwörter der Autor:innen

EGFR mutationhistological transformationlung adenocarcinomasarcomatoid carcinomasmall‐cell lung carcinoma

Substanzen

EGFR protein, humanErbB Receptors

Autor:innen und Institutionen

  • Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

ORCID-Profile: Bingyu Huang, Xiaoyan Liu, Xiaoxing Gao, Yan Xu, Minjiang Chen, Mengzhao Wang

Förderung

  • Peking Union Medical College Hospital

Zitieren

APA

Huang, B., Lu, T., Hong, R., Liu, X., Gao, X., Xu, Y., Chen, M., Zhong, W., Wang, M., & Zhao, J. (2026). Transformation to Small‐Cell Lung Carcinoma and Then to Sarcomatoid Carcinoma in an EGFR ‐Mutant Lung Adenocarcinoma Patient During Systemic Therapy: A Case Report. Thoracic Cancer, 17(21). https://doi.org/10.1111/1759-7714.70397

Vancouver

Huang B, Lu T, Hong R, Liu X, Gao X, Xu Y, et al. Transformation to Small‐Cell Lung Carcinoma and Then to Sarcomatoid Carcinoma in an EGFR ‐Mutant Lung Adenocarcinoma Patient During Systemic Therapy: A Case Report. Thoracic Cancer. 2026;17(21). doi:10.1111/1759-7714.70397

BibTeX
@article{Huang2026,
  author = {Huang, Bingyu and Lu, Tao and Hong, Ruping and Liu, Xiaoyan and Gao, Xiaoxing and Xu, Yan and Chen, Minjiang and Zhong, Wei and Wang, Mengzhao and Zhao, Jing},
  title = {Transformation to Small‐Cell Lung Carcinoma and Then to Sarcomatoid Carcinoma in an EGFR ‐Mutant Lung Adenocarcinoma Patient During Systemic Therapy: A Case Report},
  journal = {Thoracic Cancer},
  year = {2026},
  volume = {17},
  number = {21},
  doi = {10.1111/1759-7714.70397}
}
Kostenlos starten →